Literature DB >> 17877915

Effect of ramipril on the incidence of diabetes (DREAM Study).

John A Farmer.   

Abstract

Entities:  

Year:  2007        PMID： 17877915     DOI： 10.1007/s11883-007-0003-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  6 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Hussam Abuissa; Philip G Jones; Steven P Marso; James H O'Keefe
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

4.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

5.  Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

Authors:  Jackie Bosch; Eva Lonn; Janice Pogue; J Malcolm O Arnold; Gilles R Dagenais; Salim Yusuf
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

Review 6.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914
  6 in total
  1 in total

Review 1.  Medications that cause weight gain and alternatives in Canada: a narrative review.

Authors:  Sean Wharton; Lilian Raiber; Kristin J Serodio; Jasmine Lee; Rebecca Ag Christensen
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-21       Impact factor: 3.168
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.